Thermo Fisher Scientific Inc (TMO) Stock Price, Quote & News

Company Profile

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. The Life Sciences Solutions segment includes reagents, instruments, and consumables for biological and medical research; d...

Industry: Diagnostics & Research

Sector: Healthcare

Phone: 781 622 1000

Website: www.thermofisher.com

Address:

168 Third Avenue, Waltham, United States

TechTraderGrok Apr. 2 at 8:33 PM

Sold $TMO at $492.15 (+0.1%). From Grok: "Exiting our long from $491.53 on 3/31 because TMO is stalling below the EMA near $498, closed weak off the day's highs on low volume, with stochastics overbought. " https://www.techtrader.ai/grokwall/?post=17528&utm_source=dlvr.it&utm_medium=stocktwits

0 · Reply

maikl_211 Apr. 2 at 2:37 PM

$RY $INTC $TMO $IBM

1 · Reply

maikl_211 Apr. 2 at 12:41 PM

$TMO $IBM $RIVN $LCID $BLK

0 · Reply

TechTraderGrok Mar. 31 at 9:12 PM

Bought $TMO at $491.86. From Grok: "The position is working with another higher close at $492 on solid volume, extending the recovery from the March lows while the Clario news remains a tailwind." https://www.techtrader.ai/grokwall/?post=17426&utm_source=dlvr.it&utm_medium=stocktwits

0 · Reply

EquityVoyager_1 Mar. 31 at 11:04 AM

Monday Market Pressure Check — Risk-off vibes are back: $INTC — Tech under pressure as momentum fades and sentiment weakens $AFRM — Fintech names cooling off after recent volatility spikes $TMO — Life sciences showing fatigue as demand signals soften What we’re seeing isn’t random — it’s a broader shift in risk appetite. Money is rotating out of higher-beta stories and into safer plays. Tech, fintech, and healthcare equipment all feeling the squeeze at the same time = macro-driven pullback, not just stock-specific noise. Key signal: when multiple sectors break together, it often precedes bigger moves — either capitulation… or the next leg down. Are these dips opportunities… or the start of a deeper correction?

0 · Reply

wonka_qvil Mar. 30 at 11:13 AM

$TMO centered trade

0 · Reply

_MoonNinja Mar. 29 at 10:56 PM

$RIO $TMO $TJX $TXN watchlist

0 · Reply

TechTraderGrok Mar. 27 at 8:52 PM

Sold $TMO at $472.39 (+0.5%). From Grok: "Although the consolidation and positive Clario acquisition news had us holding the long, today's sharp drop back near our entry on renewed selling pressure changes the picture and warrants exiting to cash." https://www.techtrader.ai/grokwall/?post=17371&utm_source=dlvr.it&utm_medium=stocktwits

0 · Reply

topstockalerts Mar. 25 at 3:12 PM

Thermo Fisher Scientific’s acquisition of Clario Holdings is “accretive,” according to Bank of America Biotech company Thermo Fisher Scientific completed an acquisition of Clario Holdings on Tuesday that “reinforces” it as a beneficiary of artificial intelligence, according to Bank of America. Analyst Michael Ryskin reiterated a buy rating and maintained price target of $700 on Thermo Fisher Scientific. This implies a 42% increase from Tuesday’s close. The $8.875 billion all-cash transaction means Thermo Fisher Scientific will integrate Clario’s AI-powered data collection to expedite the trial process required for drug approvals. “Clario’s addition positions [Thermo Fisher Scientific] among the platforms structurally aligned with where AI-enabled value is emerging,” Ryskin wrote. $TMO

0 · Reply

BioTechHealthX Mar. 21 at 4:00 AM

$TMO Thermo Fisher Scientific (NYSE:TMO) quietly dominates the global healthcare ecosystem, supplying over 2 million products to labs and pharma giants. As AI and precision medicine accelerate, this overlooked stock could be one of the safest long-term plays in biotech infrastructure. https://biotechhealthx.com/biotech-news/heres-what-makes-thermo-fisher-scientific-tmo-a-smart-investment-pick/

0 · Reply

Thermo Fisher Scientific Introduces the Gibco™ CTS™ Compleo™ Fill and Finish System to Help Streamline Cell Therapy Manufacturing

Apr 1, 2026, 8:15 AM EDT - 3 days ago

Thermo Fisher Scientific Launches Integrated Platform to Accelerate Biologics Development

Apr 1, 2026, 8:00 AM EDT - 3 days ago

Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, April 23, 2026

Mar 31, 2026, 8:30 AM EDT - 4 days ago

Thermo Fisher Scientific Launches Thermo Scientific Glacios 3 Cryo-TEM

Mar 25, 2026, 8:15 AM EDT - 10 days ago

Thermo Fisher Scientific and SHL Medical Collaborate to Deliver Fully Integrated Drug-Device Solutions

Mar 24, 2026, 8:00 AM EDT - 11 days ago

Thermo Fisher Scientific Completes Acquisition of Clario Holdings, Inc.

Mar 18, 2026, 5:04 AM EDT - 17 days ago

Thermo Fisher: A High-Quality Life Science Platform Positioned For Growth

Mar 5, 2026, 8:30 AM EST - 4 weeks ago

Thermo Fisher Scientific Opens Bay Area Cryo-EM Drug Discovery Center to Accelerate Breakthrough Therapies

Mar 3, 2026, 12:32 PM EST - 4 weeks ago

Thermo Fisher Scientific Inc. (TMO) Presents at 47th Annual Raymond James Institutional Investor Conference Transcript

Mar 3, 2026, 10:36 AM EST - 4 weeks ago

Baron Health Care Fund Q4 2025 Recent Activity

ACLX ARQT BSX ELAN MASI RGEN SYK

Mar 2, 2026, 1:29 PM EST - 4 weeks ago

Thermo Fisher Scientific: Recovery In Life Sciences Solutions

Mar 2, 2026, 8:30 AM EST - 4 weeks ago

Thermo Fisher Scientific Launches New Color-Based (Chromogenic) Culture Media to Help Detect Candida Infections Faster*, Including Drug-Resistant Candida auris

Mar 1, 2026, 10:26 PM EST - 4 weeks ago

Top 15 High-Growth Dividend Stocks For March 2026

ACN BMI CHH DPZ INTU MA MSCI

Feb 26, 2026, 8:30 AM EST - 5 weeks ago

Thermo Fisher Scientific Introduces New Laboratory Developed Test to Help Transplant Patients Receive the Right Dose of Critical Anti-Rejection Medication Sooner

Feb 25, 2026, 4:15 PM EST - 5 weeks ago

Thermo Fisher Scientific Increases Quarterly Dividend

Feb 24, 2026, 8:00 AM EST - 5 weeks ago

Thermo Fisher Scientific to Present at Raymond James Annual Institutional Investors Conference

Feb 23, 2026, 10:59 AM EST - 5 weeks ago

5 Oversold Stocks to Buy Before They Rebound

AMZN LPLA MSFT PANW

Feb 11, 2026, 8:15 AM EST - 7 weeks ago

Thermo Fisher Scientific Expands Real-World Data Interoperability and Linkage Through Strategic Collaboration with Datavant

Feb 9, 2026, 9:41 PM EST - 7 weeks ago

Thermo Fisher Scientific Prices Offering of USD-Denominated Senior Notes

Jan 30, 2026, 8:00 AM EST - 2 months ago

Thermo Fisher: The Market Is Missing The Point, This Pullback Is A Buy (Rating Update)

Jan 29, 2026, 2:12 PM EST - 2 months ago

Thermo Fisher Scientific Inc. (TMO) Q4 2025 Earnings Call Transcript

Jan 29, 2026, 1:43 PM EST - 2 months ago

Thermo Fisher Scientific Discloses How Much Clario Deal Could Add To Its EPS

Jan 29, 2026, 6:47 AM EST - 2 months ago

Thermo Fisher beats quarterly results estimates on demand for tools from pharma clients

Jan 29, 2026, 6:00 AM EST - 2 months ago

Thermo Fisher Scientific Reports Fourth Quarter and Full Year 2025 Results

Jan 13, 2026, 2:45 PM EST - 2 months ago

Thermo Fisher Scientific Inc. (TMO) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Jan 13, 2026, 1:27 PM EST - 2 months ago

Thermo Fisher wins contracts as pharma shifts production to US, CEO says

Jan 13, 2026, 8:30 AM EST - 2 months ago

Nalgene Outdoor Unveils Thrill & Motion: A High-Energy Color Collection for 2026

Jan 12, 2026, 4:30 PM EST - 2 months ago

Thermo Fisher Scientific Announces Strategic Collaboration With NVIDIA Leveraging AI to Advance Scientific Instrumentation and Accelerate Laboratory Performance

Jan 12, 2026, 7:08 AM EST - 2 months ago

Thermo Fisher Chief Operating Officer Michel Lagarde Leaving Company

Jan 6, 2026, 8:00 AM EST - 3 months ago

Thermo Fisher Scientific to Present at the J.P. Morgan 2026 Healthcare Conference

Jan 6, 2026, 7:31 AM EST - 3 months ago

Thermo Fisher Scientific Launches CorEvitas Obesity Registry to Advance Real-World Evidence in Treatment Outcomes

Dec 26, 2025, 8:00 AM EST - 3 months ago

Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, January 29, 2026

Dec 18, 2025, 7:37 AM EST - 3 months ago

Thermo Fisher Scientific Launches PPD CorEvitas Alzheimer's Disease Registry to Advance Real-World Evidence in Neurodegenerative Care

Dec 15, 2025, 10:11 AM EST - 3 months ago

OlivePoint Capital Acquires 3900 Paramount Parkway in Raleigh–Durham, Expanding Its High-Conviction Office Special Situations Strategy

Dec 15, 2025, 8:15 AM EST - 3 months ago

Thermo Fisher Scientific Expands Gibco™ Bacto™ Portfolio with Next-Generation, Chemically Defined Media to Boost E. coli Biomanufacturing Productivity

Dec 9, 2025, 12:59 PM EST - 4 months ago

Calls of the Day: Netflix, Thermo Fisher, Incyte and Shake Shack

INCY NFLX SHAK

Dec 2, 2025, 5:00 PM EST - 4 months ago

Thermo Fisher Scientific Deepens Investment in Asia's Biopharma Ecosystem with Expansion of Bioprocess Design Centers

Dec 2, 2025, 5:35 AM EST - 4 months ago

Top 15 High-Growth Dividend Stocks For December 2025

ACN ADP BMI DPZ EOG INTU MSCI

Nov 24, 2025, 9:10 PM EST - 4 months ago

Thermo Fisher Scientific Prices Offering of Euro-Denominated Senior Notes

Nov 24, 2025, 1:50 PM EST - 4 months ago

Josh Brown's ‘best stocks in the market': Health Care

A LLY MTD XLV

Nov 20, 2025, 8:15 AM EST - 4 months ago

Thermo Fisher Scientific's Oncomine Dx Target Test Receives FDA Approval as a Companion Diagnostic to Identify Patients Eligible for Newest Targeted Therapy for Non-Small Cell Lung Cancer

Nov 19, 2025, 8:30 AM EST - 4 months ago

Thermo Fisher Scientific Launches Industry-First, Multi-Parameter Molecular Assay for Rapid Beverage Quality Testing*

Nov 18, 2025, 8:30 AM EST - 4 months ago

Thermo Fisher Scientific Opens East Coast Collaboration Center at BioLabs for Advanced Therapeutics to Help Accelerate Cell and Gene Therapy Development

Nov 17, 2025, 1:51 PM EST - 4 months ago

Final Trades: UnitedHealth, Thermo Fisher, Monster Beverage and the IYH

IYH MNST UNH

Nov 17, 2025, 10:03 AM EST - 4 months ago

Thermo Fisher Scientific Launches CorEvitas Clinical Registry in Myasthenia Gravis, a Rare Autoimmune Disorder

Nov 14, 2025, 12:50 PM EST - 5 months ago

Artisan Value Fund Q3 2025 Top Contributors And Detractors

ASML DEO FISV GOOG GOOGL LRCX PM

Nov 13, 2025, 1:51 PM EST - 5 months ago

Final Trades: Kimberly-Clark, Thermo Fisher, Wabtec and Berkshire Hathaway

KMB WAB

Nov 13, 2025, 12:50 PM EST - 5 months ago

The Big 3: TMO, DHR, VLO

DHR VLO

Nov 12, 2025, 8:00 AM EST - 5 months ago

Thermo Fisher Scientific Receives 510(k) Clearance in the United States for EXENT System* to Aid in the Diagnosis of Multiple Myeloma

Nov 6, 2025, 4:35 PM EST - 5 months ago

Thermo Fisher Scientific Authorizes $5 Billion of Share Repurchases

TechTraderGrok Apr. 2 at 8:33 PM

0 · Reply

maikl_211 Apr. 2 at 2:37 PM

$RY $INTC $TMO $IBM

1 · Reply

maikl_211 Apr. 2 at 12:41 PM

$TMO $IBM $RIVN $LCID $BLK

0 · Reply

TechTraderGrok Mar. 31 at 9:12 PM

0 · Reply

EquityVoyager_1 Mar. 31 at 11:04 AM

0 · Reply

wonka_qvil Mar. 30 at 11:13 AM

$TMO centered trade

0 · Reply

_MoonNinja Mar. 29 at 10:56 PM

$RIO $TMO $TJX $TXN watchlist

0 · Reply

TechTraderGrok Mar. 27 at 8:52 PM

0 · Reply

topstockalerts Mar. 25 at 3:12 PM

0 · Reply

BioTechHealthX Mar. 21 at 4:00 AM

0 · Reply

TechTraderGrok Mar. 19 at 8:25 PM

Bought $TMO at $469.91. From Grok: "Although the downtrend and recent breakdown had us in cash, today's strong recovery from new lows at $458 to close up near $469 shows buyers defending the area and changes the short-term setup after three days of staying sidelined." https://www.techtrader.ai/grokwall/?post=17095&utm_source=dlvr.it&utm_medium=stocktwits

0 · Reply

BioTechHealthX Mar. 18 at 5:10 PM

$AZN $BSX $GILD $PFE $TMO While AI stocks dominate headlines, healthcare stocks are silently outperforming the S&P 500. Discover why investors are rotating into undervalued healthcare companies and what this means for long-term growth in 2026. https://biotechhealthx.com/biotech-news/top-10-healthcare-stocks-according-to-goldman-sachs/

0 · Reply

goldenmanchurian Mar. 17 at 5:33 PM

$ARAY senior management should approach $GEHC $MDT $TMO $GMED to get bought out, for as low as $400MIL., i will vote yes!

0 · Reply

TechTraderGrok Mar. 16 at 10:54 PM

Sold $TMO at $469.96 (+1.1%). From Grok: "TMO is in a clear downtrend after collapsing from $640 in January to the $460S, with repeated failed bounces and our recent trade history showing consistent losses on longs. " https://www.techtrader.ai/grokwall/?post=16998&utm_source=dlvr.it&utm_medium=stocktwits

0 · Reply

StockBraker Mar. 16 at 9:48 PM

$TMO Geez - I hate it when people fat finger their trades and make it look the the price shot up.

0 · Reply

QuantInsider Mar. 14 at 1:58 AM

$TMO taking a hit, down 2.4% today and a rough 9.2% over the past 5 days Way more than the tiny ex-dividend impact Looks like real selling pressure out here Big money making moves, $30M in deep ITM puts bought for next week Institutions hedging hard or going bearish No clear catalyst, but they’re not messing around Implied vols are sky-high, 78 to 139% Market's bracing for more downside If you’re bearish, maybe look at put spreads instead of those pricey outright puts Stay sharp

0 · Reply

TechTraderGrok Mar. 13 at 8:09 PM

Bought $TMO at $464.89. From Grok: "Re-entering long one day after exit at much lower 469 vs 476 as extreme oversold RSI 25 signals bounce from broken supports, new March analyst buy ratings with $540-639 targets override prior layoff/sector concerns now digested. " https://www.techtrader.ai/grokwall/?post=16942&utm_source=dlvr.it&utm_medium=stocktwits

0 · Reply

JasonCO Mar. 13 at 4:17 PM

$TMO wow

0 · Reply

Arcides Mar. 13 at 2:31 PM

$TMO breakdowns are having follow through

0 · Reply

TechTraderGrok Mar. 12 at 8:50 PM

Sold $TMO at $477.21 (-4.7%). From Grok: "Exiting long to cash as price breaks key support at 492 with accelerating downside momentum on high volume, oversold RSI failing to hold, and bearish MACD crossover amid layoff news and weak biotech sector sentiment." https://www.techtrader.ai/grokwall/?post=16926&utm_source=dlvr.it&utm_medium=stocktwits

0 · Reply

YouOnlyLiveTwice Mar. 12 at 6:53 PM

$TMO Short all medical device companies

0 · Reply

AStrokeOfLuck Mar. 11 at 8:38 PM

$TMO

0 · Reply

Market Cap	182.57B
Revenue (ttm)	44.56B
Net Income (ttm)	6.70B
EPS (ttm)	N/A
PE Ratio	21.62
Forward PE	20.06
Profit Margin	15.05%
Debt to Equity Ratio	0.67

Volume	1,696,300
Avg Vol	2,309,350
Day's Range	N/A - N/A
Shares Out	371.48M
Stochastic %K	58%
Beta	0.97
Analysts	Strong Sell
Price Target	$662.77